Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Head and Neck Cancer

Free Subscription 20.11.2023 3 BMC Cancer 1 Br J Cancer 1 Br J Oral Maxillofac Surg 1 Clin Cancer Res 1 Gastrointest Endosc 8 Head Neck 1 Int J Radiat Oncol Biol Phys 1 J Clin Endocrinol Metab 1 J Clin Oncol 4 Laryngoscope 1 Oral Oncol 4 PLoS One 1 Radiother Oncol 7 Thyroid

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Cancer

1. SIJBEN J, Rainey L, Peters Y, Fitzgerald RC, et al
   Dutch, UK and US professionals' perceptions of screening for Barrett's esophagus and esophageal adenocarcinoma: a concept mapping study.
   BMC Cancer. 2023;23:1111.
   PubMed         Abstract available
   
   
2. ROUSSOT N, Fumet JD, Limagne E, Thibaudin M, et al
   A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer.
   BMC Cancer. 2023;23:1080.
   PubMed         Abstract available
   
   
3. HU J, Yan J, Chen Y, Li X, et al
   ESCO2 promotes hypopharyngeal carcinoma progression in a STAT1-dependent manner.
   BMC Cancer. 2023;23:1114.
   PubMed         Abstract available
   
   

   
   Br J Cancer

4. MAHMOOD H, Shephard A, Hankinson P, Bradburn M, et al
   Development and validation of a multivariable model for prediction of malignant transformation and recurrence of oral epithelial dysplasia.
   Br J Cancer. 2023;129:1599-1607.
   PubMed         Abstract available
   
   

   
   Br J Oral Maxillofac Surg

5. CHARTERS E, Stokan M, Cheng K, Dunn M, et al
   Minimum detectable change in occlusal load - Normative data for healthy and head and neck cancer populations.
   Br J Oral Maxillofac Surg. 2023 Oct 12:S0266-4356(23)00485.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

6. OU X, Zhai R, Wei W, Chen J, et al
   Induction Toripalimab And Chemotherapy For Organ Preservation In Locally Advanced Laryngeal And Hypopharyngeal Cancer: A Single-Arm Phase 2 Clinical Trial.
   Clin Cancer Res. 2023 Nov 13. doi: 10.1158/1078-0432.CCR-23-2398.
   PubMed         Abstract available
   
   

   
   Gastrointest Endosc

7. YOSHIZAKI T, Yamamoto Y, Sako T, Kitamura Y, et al
   Outcomes of endoscopic submucosal dissection for esophageal cancer with segmental absence of intestinal musculature.
   Gastrointest Endosc. 2023 Nov 10:S0016-5107(23)03043.
   PubMed         Abstract available
   
   

   
   Head Neck

8. YOU Z, Han B, Shi Z, Zhao M, et al
   Vocal cord leukoplakia classification using deep learning models in white light and narrow band imaging endoscopy images.
   Head Neck. 2023;45:3129-3145.
   PubMed         Abstract available
   
   
9. SAROUL N, Loukine M, Durand M, Pereira B, et al
   Early detection of pharyngocutaneous fistulae after total laryngectomy by cytokine in drainage: A pilot study (DEFILAC).
   Head Neck. 2023;45:3067-3074.
   PubMed         Abstract available
   
   
10. LOPEZ J, Subramanian T, Stambuk H, Schreyer M, et al
    CAD/CAM-assisted ablative surgery and intraoperative brachytherapy for pediatric skull-base sarcomas.
    Head Neck. 2023;45:E61-E66.
    PubMed         Abstract available
    
    
11. PATNI A, Rastogi M, Gandhi AK, Mishra VK, et al
    Toxicities and clinical outcome of adjuvant dysphagia optimized versus standard intensity-modulated radiotherapy for post-operative oral cavity cancers: A prospective comparative study.
    Head Neck. 2023;45:3119-3128.
    PubMed         Abstract available
    
    
12. MARTIN AM, Elliott ZT, Chisolm P, Crossley J, et al
    Perioperative complications among head and neck surgery patients with COVID-19.
    Head Neck. 2023;45:3033-3041.
    PubMed         Abstract available
    
    
13. BERNARD C, Zhang JZ, Klieb H, Blanas N, et al
    Clinical outcomes of oral epithelial dysplasia managed by observation versus excision.
    Head Neck. 2023;45:3096-3106.
    PubMed         Abstract available
    
    
14. ABBATE V, Barone S, Borriello G, Troise S, et al
    Diagnostic performance of inflammatory biomarkers and cytological analysis in salivary gland tumors.
    Head Neck. 2023;45:3015-3023.
    PubMed         Abstract available
    
    
15. COOPER DJ, Travaglia I, Guller M, Talcott WJ, et al
    Clinical predictors of premature radiotherapy terminations in senior adults with oral cavity and laryngeal carcinoma.
    Head Neck. 2023 Nov 11. doi: 10.1002/hed.27570.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

16. VASQUEZ OSORIO E, Abravan A, Green A, van Herk M, et al
    Dysphagia at 1 Year is Associated With Mean Dose to the Inferior Section of the Brain Stem.
    Int J Radiat Oncol Biol Phys. 2023;117:903-913.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

17. LI P, Liu Y, Wei T, Wang X, et al
    Effect and interactions of BRAF on lymph node metastasis in papillary thyroid carcinoma with Hashimoto's thyroiditis.
    J Clin Endocrinol Metab. 2023 Nov 15:dgad667. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

18. LORENZEN S, Gotze TO, Thuss-Patience P, Biebl M, et al
    Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial.
    J Clin Oncol. 2023 Nov 14:JCO2300975. doi: 10.1200/JCO.23.00975.
    PubMed         Abstract available
    
    

    
    Laryngoscope

19. YOSEFOF E, Tsur N, Zavdy O, Kurman N, et al
    Prognostic Significance of Regional Disease in Young Patients with Oral Cancer: A Comparative Study.
    Laryngoscope. 2023 Nov 15. doi: 10.1002/lary.31187.
    PubMed         Abstract available
    
    
20. THARAKAN T, Piccirillo JF, Miller B, Reed DR, et al
    Acute Taste Dysfunction in Oropharyngeal Cancer Patients after Transoral Robotic Surgery.
    Laryngoscope. 2023;133:3520-3528.
    PubMed         Abstract available
    
    
21. KING RE, Bilger A, Rademacher J, Lambert PF, et al
    Preclinical Models of Laryngeal Papillomavirus Infection: A Scoping Review.
    Laryngoscope. 2023;133:3256-3268.
    PubMed         Abstract available
    
    
22. NGUYEN J, Patel R, Eloy JA, Baredes S, et al
    Assessing the Association Between Time to Surgery and Survival in Sinonasal Squamous Cell Carcinoma.
    Laryngoscope. 2023;133:3389-3395.
    PubMed         Abstract available
    
    

    
    Oral Oncol

23. CHEN AM, Harris JP, Tjoa T, Haidar Y, et al
    Racial disparities in the timely receipt of adjuvant radiotherapy for head and neck cancer.
    Oral Oncol. 2023;147:106611.
    PubMed         Abstract available
    
    

    
    PLoS One

24. SHETAKE NG, Kumar A, Huilgol N, Pandey BN, et al
    Diagnostic potential of serum HSP90 beta for HNSCC and its therapeutic prognosis after local hyperthermia therapy.
    PLoS One. 2023;18:e0281919.
    PubMed         Abstract available
    
    
25. ZAMANI N, Szymiczek A, Shakeri R, Poustchi H, et al
    A Single nucleotide polymorphism in the ALDH2 gene modifies the risk of esophageal squamous cell carcinoma in BRCA2 p.K3326* carriers.
    PLoS One. 2023;18:e0292611.
    PubMed         Abstract available
    
    
26. HEO J, Lee S, Park J, Yang H, et al
    Age-associated mortality is partially mediated by TERT promoter mutation status in differentiated thyroid carcinoma.
    PLoS One. 2023;18:e0294145.
    PubMed         Abstract available
    
    
27. KANANKULAM VELLIANGIRI S, Ballal S, Prasad Yadhav M, Tripathi M, et al
    A long-term retrospective cohort-based risk-benefit analysis of augmenting total cumulative I-131 activity to 37GBq in differentiated thyroid cancer patients with skeletal metastases.
    PLoS One. 2023;18:e0294343.
    PubMed         Abstract available
    
    

    
    Radiother Oncol

28. BERBEE M, Muijs CT, Voncken FEM, Wee LS, et al
    External validation of a lung cancer-based prediction model for two-year mortality in esophageal cancer patient cohorts.
    Radiother Oncol. 2023 Nov 8:109979. doi: 10.1016/j.radonc.2023.109979.
    PubMed         Abstract available
    
    

    
    Thyroid

29. YAN S, Li X, Yan B
    Letter to the Editor: Could Radioactive Iodine Be a Preferred Therapy for Graves' Hyperthyroidism Patients with Large Goiters? A Viewpoint from China.
    Thyroid. 2023 Aug 18. doi: 10.1089/thy.2023.0332.
    PubMed        
    
    
30. ROSS DS
    Response to Yan et al. re "Could Radioactive Iodine be a Preferred Therapy for Graves' Hyperthyroidism Patients with Large Goiters? A Viewpoint from China.
    Thyroid. 2023 Aug 25. doi: 10.1089/thy.2023.0423.
    PubMed         Abstract available
    
    
31. FAGIN JA, Nikiforov YE
    Progress in Thyroid Cancer Genomics: A 40-Year Journey.
    Thyroid. 2023 Sep 4. doi: 10.1089/thy.2023.0045.
    PubMed         Abstract available
    
    
32. MOOG S, Lamartina L, Bani MA, Al Ghuzlan A, et al
    Alkylating Agent-Induced High Tumor Mutational Burden in Medullary Thyroid Cancer and Response to Immune Checkpoint Inhibitors: Two Case Reports.
    Thyroid. 2023;33:1368-1373.
    PubMed         Abstract available
    
    
33. BALAKIROUCHENANE D, Seban R, Groussin L, Puszkiel A, et al
    Pharmacokinetics/Pharmacodynamics of dabrafenib and trametinib for redifferentiation and treatment of radioactive-iodine-resistant mutated advanced differentiated thyroid cancer.
    Thyroid. 2023 Sep 19. doi: 10.1089/thy.2023.0228.
    PubMed         Abstract available
    
    
34. DE LEO S, D'Elia S, Grani G, Dondi F, et al
    A Prospective, Multicenter Study Examining the Relationship between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis.
    Thyroid. 2023 Sep 19. doi: 10.1089/thy.2023.0052.
    PubMed         Abstract available
    
    
35. GUPTA M, Misariu AM, Saydy N, Nichols A, et al
    A Multicentre Retrospective Study of Anaplastic Thyroid Cancer in the Era of Targeted Therapy in a Public Health Care System: Canada's Experience.
    Thyroid. 2023 Sep 19. doi: 10.1089/thy.2023.0088.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.